SK Biopharmaceuticals bags XCOPRI FDA approval for partial-onset seizures
XCOPRI FDA approval : SK Biopharmaceuticals said that its US subsidiary SK Life Science has been granted approval from the US Food and Drug Administration (FDA) ... Read More
Stokes’ STK-001 secures FDA orphan drug designation for Dravet Syndrome
US biotech company Stoke Therapeutics has secured orphan drug designation for its lead product candidate - STK-001 from the US Food and Drug Administration (FDA) ... Read More
Martindale Pharma’s Epaclob and Silocalm gain regulatory approval in seven European countries
Martindale Pharma, a UK-based global pharmaceutical company, has successfully secured regulatory approval for its innovative clobazam oral suspension, branded as Epaclob and Silocalm, in seven ... Read More